Literature DB >> 20822454

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

Jonathan A McCullers1, Julie L McAuley, Sarah Browall, Amy R Iverson, Kelli L Boyd, Birgitta Henriques Normark.   

Abstract

The role of respiratory viruses in the transmission of Streptococcus pneumoniae is poorly understood. Key questions, such as which serotypes are most fit for transmission and disease and whether influenza virus alters these parameters in a serotype-specific manner, have not been adequately studied. In a novel model of transmission in ferrets, we demonstrated that pneumococcal transmission and disease were enhanced if donors had previously been infected with influenza virus. Bacterial titers in nasal wash, the incidence of mucosal and invasive disease, and the percentage of contacts that were infected all increased. In contact ferrets, viral infection increased their susceptibility to S. pneumoniae acquisition both in terms of the percentage infected and the distance over which they could acquire infection. These influenza-mediated effects on colonization, transmission, and disease were dependent on the pneumococcal strain. Overall, these data argue that the relationship between respiratory viral infections, acquisition of pneumococci, and development of disease in humans needs further study to be better understood.

Entities:  

Mesh:

Year:  2010        PMID: 20822454      PMCID: PMC3249639          DOI: 10.1086/656333

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  A functional genomic analysis of type 3 Streptococcus pneumoniae virulence.

Authors:  G W Lau; S Haataja; M Lonetto; S E Kensit; A Marra; A P Bryant; D McDevitt; D A Morrison; D W Holden
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

2.  Clonal success of piliated penicillin nonsusceptible pneumococci.

Authors:  K Sjöström; C Blomberg; J Fernebro; J Dagerhamn; E Morfeldt; M A Barocchi; S Browall; M Moschioni; M Andersson; F Henriques; B Albiger; Rino Rappuoli; S Normark; B Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-20       Impact factor: 11.205

3.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Authors:  Julie L McAuley; Felicita Hornung; Kelli L Boyd; Amber M Smith; Raelene McKeon; Jack Bennink; Jonathan W Yewdell; Jonathan A McCullers
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

4.  Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon.

Authors:  K P Francis; J Yu; C Bellinger-Kawahara; D Joh; M J Hawkinson; G Xiao; T F Purchio; M G Caparon; M Lipsitch; P R Contag
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

6.  Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Authors:  C Blomberg; J Dagerhamn; S Dahlberg; S Browall; J Fernebro; B Albiger; E Morfeldt; S Normark; B Henriques-Normark
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

Review 7.  How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

Authors:  Philippe De Wals; Lonny Erickson; Béatrice Poirier; Jacques Pépin; Michael E Pichichero
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

8.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.

Authors:  Matthew W Smith; Jeffrey E Schmidt; Jerold E Rehg; Carlos J Orihuela; Jonathan A McCullers
Journal:  Comp Med       Date:  2007-02       Impact factor: 0.982

9.  Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors.

Authors:  David L Hava; Andrew Camilli
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

10.  Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Asa Karlström; Amy R Iverson; Jutta M Loeffler; Vincent A Fischetti
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

View more
  120 in total

1.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

2.  Unveiling the burden of influenza-associated pneumococcal pneumonia.

Authors:  Carlos G Grijalva; Marie R Griffin
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

3.  Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec.

Authors:  Zhou Zhou; Rodica Gilca; Geneviève Deceuninck; François Boucher; Philippe De Wals
Journal:  Can J Public Health       Date:  2020-06-11

4.  Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Lauren B King; Antonia C Perez; Kyle A Murrah; Jennifer L Reimche; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

5.  Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens.

Authors:  Nopporn Apiwattanakul; Paul G Thomas; Raymond E Kuhn; De'Broski R Herbert; Jonathan A McCullers
Journal:  Med Microbiol Immunol       Date:  2014-06-21       Impact factor: 3.402

6.  Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease.

Authors:  Padmini S Pillai; Ryan D Molony; Kimberly Martinod; Huiping Dong; Iris K Pang; Michal C Tal; Angel G Solis; Piotr Bielecki; Subhasis Mohanty; Mark Trentalange; Robert J Homer; Richard A Flavell; Denisa D Wagner; Ruth R Montgomery; Albert C Shaw; Peter Staeheli; Akiko Iwasaki
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

7.  Pathogen replication, host inflammation, and disease in the upper respiratory tract.

Authors:  Michael J Mina; Keith P Klugman
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

Review 8.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

9.  Identifying the interaction between influenza and pneumococcal pneumonia using incidence data.

Authors:  Sourya Shrestha; Betsy Foxman; Daniel M Weinberger; Claudia Steiner; Cécile Viboud; Pejman Rohani
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

10.  1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Authors:  Kathie-Anne Walters; Felice D'Agnillo; Zong-Mei Sheng; Jason Kindrachuk; Louis M Schwartzman; Rolf E Kuestner; Daniel S Chertow; Basil T Golding; Jeffery K Taubenberger; John C Kash
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.